Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1998;97:589-595

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zucker, T.-Ph.
Right arrow Articles by Schrör, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zucker, T.-Ph.
Right arrow Articles by Schrör, K.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH

(Circulation. 1998;97:589-595.)
© 1998 American Heart Association, Inc.


Basic Science Reports

Thrombin-Induced Mitogenesis in Coronary Artery Smooth Muscle Cells Is Potentiated by Thromboxane A2 and Involves Upregulation of Thromboxane Receptor mRNA

T.-Ph. Zucker, MD; D. Bönisch, BSc; S. Muck, BSc; A.-A. Weber, MD; E. Bretschneider, MD; E. Glusa, MD; ; K. Schrör, MD

From Institut für Pharmakologie (D.B., S.M., A.-A.W., K.S.) and Institut für Klinische Anaesthesiologie, Heinrich-Heine-Universität Düsseldorf (Germany) (T.-Ph.Z.); and Forschungszentrum für Vaskuläre Biologie und Medizin der Friedrich-Schiller-Universität Jena, Erfurt, Germany (E.B., E.G.).

Correspondence to Karsten Schrör, MD, Institut für Pharmakologie, Heinrich-Heine-Universität Düsseldorf, Moorenstr 5, D-40225 Düsseldorf, Germany. E-mail schroer{at}pharma.uni-duesseldorf.de

Background—Previous studies have shown that thrombin is a potent though slow-acting mitogen for vascular smooth muscle cells (SMC). Because thrombin generation in vivo is accompanied by platelet activation, it has been suggested that platelet-derived factors might enhance thrombin-induced SMC proliferation. No information is available so far on the possible role of thromboxane A2.

Methods and Results—Thrombin (1 U/mL) caused a threefold to fourfold increase of DNA synthesis in cultured bovine coronary artery SMC as assessed from [3H]thymidine incorporation. U 46619, a stable thromboxane A2 mimetic, had only a minor stimulating effect on its own but potentiated the thrombin effect sixfold to sevenfold above control (P<.05). These findings were paralleled by a 52±5% (P<.05) increase in cell number at 48 hours after addition of both mitogens as compared with 24±5% with thrombin alone and no change with U 46619 alone. Thromboxane A2 receptor mRNA was found to be upregulated sixfold 20 minutes after thrombin stimulation. Pretreatment of SMC with thrombin for 4 hours markedly increased U 46619–induced mitogen-activated protein kinase activity, indicating thrombin-induced upregulation of functional thromboxane receptors in SMC.

Conclusions—Thrombin-induced proliferation of SMC is markedly enhanced by thromboxane A2. This might result in an enhancement of SMC proliferation by platelet-derived thromboxane A2 in vivo.


Key Words: growth substances • cells • muscle, smooth




This article has been cited by other articles:


Home page
CirculationHome page
A. Haider, I. Lee, J. Grabarek, Z. Darzynkiewicz, and N. R. Ferreri
Dual Functionality of Cyclooxygenase-2 as a Regulator of Tumor Necrosis Factor-Mediated G1 Shortening and Nitric Oxide-Mediated Inhibition of Vascular Smooth Muscle Cell Proliferation
Circulation, August 26, 2003; 108(8): 1015 - 1021.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Yaekashiwa and L.-H. Wang
Transcriptional Control of the Human Thromboxane Synthase Gene in Vivo and in Vitro
J. Biol. Chem., June 14, 2002; 277(25): 22497 - 22508.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
E. Connolly, D. J. Bouchier-Hayes, E. Kaye, A. Leahy, D. Fitzgerald, and O. Belton
Cyclooxygenase Isozyme Expression and Intimal Hyperplasia in a Rat Model of Balloon Angioplasty
J. Pharmacol. Exp. Ther., February 1, 2002; 300(2): 393 - 398.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S.-i. Saitoh, F. Onogi, K. Aikawa, M. Muto, T. Saito, K. Maehara, and Y. Maruyama
Multiple endothelial injury in epicardial coronary artery induces downstream microvascular spasm as well as remodeling partly via thromboxane A2
J. Am. Coll. Cardiol., January 1, 2001; 37(1): 308 - 315.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
W. Young, K. Mahboubi, A. Haider, I. Li, and N. R. Ferreri
Cyclooxygenase-2 Is Required for Tumor Necrosis Factor-{alpha}- and Angiotensin II-Mediated Proliferation of Vascular Smooth Muscle Cells
Circ. Res., April 28, 2000; 86(8): 906 - 914.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Ikeda, A. Sugawara, Y. Taniyama, A. Uruno, K. Igarashi, S. Arima, S. Ito, and K. Takeuchi
Suppression of Rat Thromboxane Synthase Gene Transcription by Peroxisome Proliferator-activated Receptor gamma in Macrophages via an Interaction with NRF2
J. Biol. Chem., October 13, 2000; 275(42): 33142 - 33150.
[Abstract] [Full Text] [PDF]